SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001714899-20-000005
Filing Date
2020-01-14
Accepted
2020-01-14 09:04:07
Documents
3
Period of Report
2020-01-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8-kjanuary2020.htm 8-K 40910
2 EX-99.1 ex991pressreleasejanua.htm EX-99.1 21929
3 image11.jpg GRAPHIC 30236
  Complete submission text file 0001714899-20-000005.txt   105494
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38311 | Film No.: 20525070
SIC: 2836 Biological Products, (No Diagnostic Substances)